Known as synthetic correlated diffusion imaging (CDI), the new technology highlights those differences by capturing, synthesizing and mixing MRI signals at different gradient pulse strengths and ...

The financial results for Anteris for the year ended December 31, 2024 are reviewed below. All amounts in $ refer to U.S. dollars. In 2024, Net Sales were $2.7 million relating to sales of our tissue ...

LOUISVILLE, Colo., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Boulder Imaging, a leader in machine vision and artificial intelligence solutions, is proud to announce the world's first Common Detector ...

Imaging technology developed and refined at the University of Waterloo promises better detection and treatment of breast cancer by more accurately pinpointing cancerous tissue. First successfully ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed ...

A new imaging technology developed at the University of Waterloo could improve how doctors detect and treat breast cancer by making cancerous tissue stand out more clearly from healthy tissue. The ...

Known as synthetic correlated diffusion imaging (CDI), the new technology highlights those differences by capturing, synthesizing and mixing MRI signals at different gradient pulse strengths and ...

Bacteria navigate tradeoffs between phage resistance and interbacterial competition. This study reveals that while LPS ...